Iron Chelation Therapy with Deferasirox Results in Improvement of Liver Enzyme Level in Patients with Iron Overload-Associated Liver Dysfunction

Iron chelation therapy (ICT) has been applied for the patients with iron overload-associated liver dysfunction since it is one of the causes of death in patients with intractable hematological diseases requiring multiple red blood cell transfusions. Recently, deferasirox (DSX), a novel, once-daily o...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Yasuo, Matsui, Yusuke, Kaneko, Hitomi, Watanabe, Mitsumasa, Tsudo, Mitsuru
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879552/
https://www.ncbi.nlm.nih.gov/pubmed/20592762
http://dx.doi.org/10.1155/2010/675060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879552/
https://www.ncbi.nlm.nih.gov/pubmed/20592762
http://dx.doi.org/10.1155/2010/675060

Ejemplares similares